3rd Translational Research Conference
Immune & Cellular Therapies:
Focus on Advanced Gene-Engineered Immune Cells
Chairs: Chiara Bonini, Michael Hudecek, Stanley Riddell

3rd Translational Research Conference
Immune & Cellular Therapies:
Focus on Advanced Gene-Engineered Immune Cells
Information
ABOUT THE CONFERENCE:
The ESH 3rd Translational Research Conference on IMMUNE & CELLULAR THERAPIES: Focus on Advanced Gene-Engineered Immune Cells proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.
It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in immune & cellular therapies with a focus on advanced gene-engineered immune cells.
New data will be presented and spirited debates on how to best to apply these insights to the future of immune & cellular therapies are expected.
SCIENTIFIC TOPICS:
• Predisposition and aging
• Clinical development of CAR-T cell therapy
• Emerging targets for cell therapy
• Receptor engineering for tumor therapy
• Gene editing to enhance efficacy
• Novel cell types and sources - beyond autologous
• Engineering immune cells in vivo
• Correlative analyses of response and resistance
• Overcoming barriers to improve response
• The future of engineered cell therapy
Programme
Read the final programme!